• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE HELEX SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE HELEX SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL Back to Search Results
Catalog Number HX2025
Device Problems Inadequacy of Device Shape and/or Size (1583); Stretched (1601); Failure to Advance (2524)
Patient Problem Embolism (1829)
Event Date 02/26/2014
Event Type  Injury  
Event Description
It was reported the physician was implanting a gore helex septal occluder to close a multifenestrated atrial septal defect.Using balloon sizing, the superior defect measured 8mm.The spread from the superior defect to the multifenestrated central defect was 18-19mm.The physician chose to close the larger superior defect and then re-evaluate the central defect.A 25mm gore helex septal occluder was implanted in the superior defect with no issues.A 10fr.Helex catheter was too large to be advanced through the central multifenestrated defect, so a 7fr.Numed 20mm sizing balloon was used to get across the defect.While inflating the balloon as the defect was being stretched, the superior 25mm helex device embolized to the left pulmonary artery.Multiple snares and forceps were attempted to grab the flat device but the physician was unable to retrieve the occluder.The patient was sent for surgical closure, which went well.The patient was doing well the next day.
 
Manufacturer Narrative
The review of the manufacturing records verified that this lot met all pre-release specifications.
 
Manufacturer Narrative
A review of the fluoroscopy images stated the following: the patient had multiple defects that required closure.A 25mm gore helex septal occluder was first implanted with part of the left disc in the right side of the septum.The 25mm gore helex septal occluder remained stable at the time of implant.It was reported that during the balloon sizing of the second defect, the balloon may have stretched the septum and caused the 25mm gore helex septal occluder to dislodge from the septum and embolize to the right pulmonary artery branch.After several attempts were made to remove the embolized occluder from the right pulmonary artery branch, the physician decided to send the patient to surgery to have the occluder removed and the defect repaired.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE HELEX SEPTAL OCCLUDER
Type of Device
OCCLUDER, TRANSCATHETER SEPTAL
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
dan kitterman
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key3683800
MDR Text Key4288891
Report Number2017233-2014-00140
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/24/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2016
Device Catalogue NumberHX2025
Device Lot Number12031974
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/03/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
HEPARIN - (B)(6) 2014
Patient Outcome(s) Other;
Patient Age30 YR
Patient Weight183
-
-